MedTrace Logo

Multiparametric MRI as a Non-Invasive Biomarker of the Tumor Microenviroment

NCT04803084 · Status: SUSPENDED · Type: OBSERVATIONAL · Enrollment: 10

Last updated 2024-11-20

No results posted yet for this study

Summary

This study is looking at how an imaging test could help doctors understand if a patient with early breast cancer will respond to drugs that use the patient's immune system to fight cancer.

Conditions

Interventions

OTHER

Tempus assay

Blood collection

OTHER

Advanced pathology 1

Tissue procurement (from diagnostic biopsy)

OTHER

Advanced pathology 2

Tissue procurement (from research biopsy)

Sponsors & Collaborators

  • National Cancer Institute (NCI)

    collaborator NIH

  • Laura Kennedy

    lead OTHER

Principal Investigators

  • Laura Kennedy, MD, PhD · Vanderbilt Medical Center

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-08-09
Primary Completion
2025-08-31
Completion
2025-08-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04803084 on ClinicalTrials.gov